首页> 外文期刊>Journal of Kathmandu Medical College >From sixth to seventh edition of tumor, node, metastasis: Stage migration in lung cancer at a tertiary care hospital in Nepal
【24h】

From sixth to seventh edition of tumor, node, metastasis: Stage migration in lung cancer at a tertiary care hospital in Nepal

机译:从第六版到第七版的肿瘤,淋巴结转移:尼泊尔三级医院的肺癌分期迁移

获取原文
       

摘要

Background: Lung cancer is the leading cause of cancer related morbidity and mortality accounting for 15.4 % of total cancer in Nepal. With revision of the Lung cancer staging system by International Association for the Study of Lung Cancer and adoption of seventh edition of staging system by American Joint Committee on Cancer in 2010, the application of seventh edition of staging system has significant impact on stage of disease which ultimately defines treatment strategy and overall prognosis. Objective: To improve stage precision by adapting new staging system, this will directly refl ect on disease treatment, survival and prognosis. Methodology: Medical records of 151 patients with lung cancer attending Oncology Department, between 2015 and 2016 were retrospectively reclassified using both sixth and seventh editions of staging system. Data were collected compared and managed using Statistical Package for Social Sciences. Ethical clearance was obtained from Institutional Review Board. Results: Stage migration was seen in 15.23 % of total cases. Seven percent of cases staged down from IIIB to IIIA. Four percent were staged up from IIIB to IV. Remaining were down staged from T4 to T3 and T3 to T2 due to sub categorization of tumor by size in seventh edition. Conclusions: There was downstage from IIIB to IIIA and upstage from IIIB to IV because of revised staging system. Thus, it is essential to have detailed radiological staging and routine pleural fluid cytology before initiation of treatment, which will further help to stage accurately and treat properly. This carries direct impact on prognosis and survival.
机译:背景:肺癌是与癌症相关的发病率和死亡率的主要原因,占尼泊尔总癌症的15.4%。随着国际肺癌研究协会对肺癌分期系统的修订以及美国癌症联合委员会于2010年采用第七版分期系统,第七版分期系统的应用对疾病分期产生了重大影响,最终确定治疗策略和总体预后。目的:通过采用新的分期系统提高分期精度,这将直接影响疾病的治疗,生存和预后。方法:使用第六版和第七版分期系统对2015年至2016年间151例就诊于肿瘤科的肺癌患者的病历进行回顾性重新分类。使用“社会科学统计软件包”对数据进行比较和管理。从机构审查委员会获得道德许可。结果:占总病例的15.23%可见阶段转移。 7%的案例从IIIB降为IIIA。从IIIB升级到IV的比例为4%。由于肿瘤在第七版中按大小细分,其余的从T4降到T3,从T3降到T2。结论:由于分期系统的修订,从IIIB到IIIA的阶段较早,从IIIB到IV的阶段较早。因此,在开始治疗之前进行详细的放射学分期和常规胸膜细胞学检查至关重要,这将进一步帮助准确分期并正确治疗。这直接影响预后和生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号